Director Allen Patricia L bought Zenas BioPharma, Inc. ($ZBIO) shares on the open market four times over the past year, totaling nearly $500,000. Her most recent purchase occurred on February 13, 2026. These buys rank her 863rd among 4,983 insiders in our database by purchase value, below the average of $1.46 million across 3.3 transactions per insider. She reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | P | Common Stock | 5000 | $23.77 | 5,000.0000 | 42,159,340 | 9999.99% | 0.01% |
| Feb. 12, 2026 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | P | Common Stock | 5700 | $24.34 | 10,700.0000 | 42,159,340 | 114.00% | 0.01% |
| Feb. 12, 2026 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | P | Common Stock | 5000 | $26.50 | 15,700.0000 | 42,159,340 | 46.73% | 0.01% |
| Feb. 13, 2026 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | P | Common Stock | 4160 | $26.36 | 19,860.0000 | 42,159,340 | 26.50% | 0.01% |
| June 10, 2025 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 41,800,802 | 9999.99% | 0.04% |
| Sept. 12, 2024 | Zenas BioPharma, Inc. | $ZBIO | Allen Patricia L | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 1,567,269 | 9999.99% | 1.18% |